The reports have been updated with the most recent Ukraine-Russia War impact on market growth for all 27+ industries. The reports also provide possible solutions and opportunities for surviving this crisis.

Avail a limited period discount of 33% on our uniquely designed Opportunities and Strategies market research reports. Contact us today and make winning strategies!

The antibody drug conjugates market is forecasted to achieve exponential growth in the coming few years with a forecast CAGR (compound annual growth rate) of 22%, as per The Business Research Company’s market report!

Read More On The Antibody Drug Conjugates Market Report 2022 – https://www.thebusinessresearchcompany.com/report/antibody-drug-conjugates-global-market-report

The Antibody Drug Conjugates Market Size In 2022 And Forecast

The global antibody drug conjugates market is expected to grow from $4.79 billion in 2021 to $5.90 billion in 2022 at a compound annual growth rate (CAGR) of 23.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, affecting many markets across the globe. The antibody-drug conjugates (ADCs) market is expected to reach $13.06 billion in 2026 at a CAGR of 22%.

The antibody-drug conjugates (ADCs) market consists of sales of antibody-drug conjugates. Antibody-drug conjugates are complex engineered therapeutics consisting of monoclonal antibodies, directed toward tumor-associated antigens, to which highly potent cytotoxic agents are attached using chemical linkers.

Request for A Sample Of The Global Antibody Drug Conjugates Market Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2569&type=smp

Rise In The Incidences Of Cancer Globally Is Driving The Growth Of The Antibody Drug Conjugates Market

The Cancer Research UK predicts that there will be 27.5 million new cases of cancer each year by 2040. The rising incidences of cancer are expected to increase the demand for antibody drug conjugates driving market growth.

Competitive Landscape And The Regional Analysis Of The Antibody Drug Conjugates Market

Major players in the antibody drug conjugates market are Bayer AG, Concortis Biotherapeutics, F. Hoffman-La Roche Ltd., Immunomedics Inc., Oxford BioTherapeutics, Pfizer Inc., Seattle GeneticsInc., Takeda Pharmaceutical Company Limited, Abbvie Inc. and Astellas Pharma/Agensys.

Additionally, as per TBRC’s research – North America was the largest region in the antibody drug conjugates market in 2021 holding the largest market share and Middle East is expected to be the fastest-growing region in the forecast period.

The Antibody Drug Conjugates Global Market Report 2022  covers regional data on key drivers, opportunities, and strategies for the seven major regions of the world that are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the antibody drug conjugates market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The report includes market size and forecast market shares for all the regions and countries with respect to the major players of the antibody drug conjugates market.

Technological Advancement – A Key Trend In The Antibody Drug Conjugates Market

Manufacturers of antibody drug conjugates are increasingly collaborating or partnering with other companies to share technology, resources, product knowledge and expand business.

Antibody Drug Conjugates Market Segmentation By The Business Research Company

1) By Type: Monoclonal Antibodies, Linker, Drug/Toxin, Others

2) By Application: Blood Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Brain Tumor, Others

3) By Product: Adcertis, Kadcyla, Others

4) By Technology: Immunogen Technology, Seattle Genetics Technology, Immunomedics Technology, Others

5) By End-User: Hospital, Clinics, Others

Here Are Some Reports Related To The Antibody Drug Conjugates Market –

Conjugated Monoclonal Antibodies Global Market Report 2022

Monoclonal Antibodies (MAbs) Global Market Report 2022

Brain Tumor Drugs Market 2022

Get In Touch With Us – Call us at:

Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708

Found this article helpful? Share it on: